Baijin Xia
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 6
- CAR-T cell therapy research 6
-
- HIV/AIDS drug development and treatment 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Hui Zhang (12 shared papers)Bingfeng Liu (9 shared papers)Lijuan Lu (4 shared papers)Fan Zou (4 shared papers)Yingtong Lin (6 shared papers)Yiwen Zhang (4 shared papers)Wanying Zhang (6 shared papers)Qifei Hu (2 shared papers)
- Journals
- Nature Communications (2 papers)Journal of Virology (2 papers)mBio (2 papers)Signal Transduction and Targeted Therapy (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- ChinaUnited StatesNigeria
In The Last Decade
Baijin Xia
14 papers receiving 257 citations
Peers
Comparison fields: 5 of 44
- Oncology 165
- Immunology 81
- Virology 14
- Infectious Diseases 38
- Molecular Biology 86
Countries citing papers authored by Baijin Xia
This map shows the geographic impact of Baijin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baijin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baijin Xia more than expected).
Fields of papers citing papers by Baijin Xia
This network shows the impact of papers produced by Baijin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baijin Xia. The network helps show where Baijin Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Baijin Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 96 | |
| 2 | 2023 | 37 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 23 | |
| 5 | 2023 | 23 | |
| 6 | 2024 | 13 | |
| 7 | 2019 | 10 | |
| 8 | 2024 | 9 | |
| 9 | 2022 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2025 | 4 | |
| 13 | 2025 | 4 | |
| 14 | 2025 | 2 | |
| 15 | 2026 | 0 | |
| 16 | 2024 | 0 |
About Baijin Xia
Baijin Xia is a scholar working on Oncology, Infectious Diseases, Virology, Molecular Biology and Emergency Medicine, having authored 16 papers that have together received 263 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV-related health complications and treatments (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Acute Myeloid Leukemia Research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Nanowire Synthesis and Applications (1 paper). The work is most often cited by research in Oncology (165 citations), Immunology (81 citations), Virology (14 citations), Infectious Diseases (38 citations) and Molecular Biology (86 citations). Baijin Xia has collaborated with scholars based in China, United States and Nigeria. Frequent co-authors include Hui Zhang, Bingfeng Liu, Lijuan Lu, Fan Zou, Yingtong Lin, Yiwen Zhang, Wanying Zhang, Qifei Hu, Mei Huang and Jun Liu. Their work appears in journals such as Nature Communications, Journal of Virology, mBio, Signal Transduction and Targeted Therapy and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.